In order to further study the anti-hepatic mechanism of celecoxib combined with metformin against HCC, we used immunohistochemical staining to detect p-mTOR in liver tissue of each group of rats, and found that the positive expression rate of p-mTOR in the combination group was lowest. The gene discussed is MTOR; the disease is hepatocellular carcinoma.